KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Common Equity (2016 - 2026)

Johnson & Johnson's Common Equity history spans 18 years, with the latest figure at $81.2 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 3.94% to $81.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $81.2 billion, a 3.94% increase, with the full-year FY2025 number at $81.5 billion, up 14.06% from a year prior.
  • Common Equity hit $81.2 billion in Q1 2026 for Johnson & Johnson, roughly flat from $81.5 billion in the prior quarter.
  • Over the last five years, Common Equity for JNJ hit a ceiling of $81.5 billion in Q4 2025 and a floor of $68.8 billion in Q4 2023.
  • Historically, Common Equity has averaged $74.8 billion across 5 years, with a median of $74.7 billion in 2022.
  • Biggest five-year swings in Common Equity: increased 16.98% in 2022 and later dropped 10.46% in 2023.
  • Tracing JNJ's Common Equity over 5 years: stood at $74.6 billion in 2022, then dropped by 7.81% to $68.8 billion in 2023, then rose by 3.95% to $71.5 billion in 2024, then rose by 14.06% to $81.5 billion in 2025, then decreased by 0.44% to $81.2 billion in 2026.
  • Business Quant data shows Common Equity for JNJ at $81.2 billion in Q1 2026, $81.5 billion in Q4 2025, and $79.3 billion in Q3 2025.